1h Free Analyst Time
The cancer therapies market in europe is forecasted to grow by USD 28.6 billion during 2023-2028, accelerating at a CAGR of 6.7% during the forecast period. The report on the cancer therapies market in europe provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increased prevalence of cancer, introduction of combination therapies, and increasing awareness about effective therapies in patient population.
The cancer therapies market in europe is segmented as below:
By Type
- Chemotherapy
- Targeted therapy
- Immunotherapy
- Others
By Geographical Landscape
- Europe
The report on the cancer therapies market in europe covers the following areas:
- Cancer Therapies Market in Europe sizing
- Cancer Therapies Market in Europe forecast
- Cancer Therapies Market in Europe industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by Type
9 Customer Landscape
10 Geographic Landscape
11 Drivers, Challenges, and Opportunity/Restraints
12 Competitive Landscape
13 Competitive Analysis
14 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the cancer therapies market in europe: AbbVie Inc., Amgen Inc., Apotex Inc., AstraZeneca Plc, Bayer AG, Bristol Myers Squibb Co., Cipla Inc., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Fresenius Kabi AG, GlaxoSmithKline Plc, Lupin Ltd., Merck and Co. Inc., Novartis AG, Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., and Viatris Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is rise in research and development investment."
According to the report, one of the major drivers for this market is the increased prevalence of cancer.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc.
- Amgen Inc.
- Apotex Inc.
- AstraZeneca Plc
- Bayer AG
- Bristol Myers Squibb Co.
- Cipla Inc.
- Eli Lilly and Co.
- F. Hoffmann La Roche Ltd.
- Fresenius Kabi AG
- GlaxoSmithKline Plc
- Lupin Ltd.
- Merck and Co. Inc.
- Novartis AG
- Pfizer Inc.
- Sanofi SA
- Sun Pharmaceutical Industries Ltd.
- Takeda Pharmaceutical Co. Ltd.
- Viatris Inc.
